Literature DB >> 18316337

Consequence of neo-antigenicity of the 'altered self'.

P Eggleton1, R Haigh, P G Winyard.   

Abstract

Post-translational modifications play a central role in determining the function of proteins. Such protein modifications come in a great variety of guises, and include phosphorylation, proteolysis, glycosylation, citrullination and oxidative modifications. In relation to inflammatory autoimmune diseases, some post-translational modifications appear to result in the generation of new antigens, and hence autoantibodies. Examples include: the induction of peptide immunogenicity by the spontaneous conversion of aspartic acid residues to isoaspartic acid; granzyme B-mediated cleavage of SLE autoantigens; the oxidative modification--on the surface of apoptotic cells--of lipids and proteins, rendering them immunogenic; and the presence of antibodies to oxidatively modified type II collagen and C1q in RA and SLE patients, respectively. The measurement of autoantibodies to citrullinated proteins has been verified as a very useful diagnostic tool in RA. Proteomics techniques, in principle, allow the detection of all types of in vivo protein modifications, and the increasing application of such technologies to the study of rheumatological diseases will further our understanding of autoantigenicity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18316337     DOI: 10.1093/rheumatology/ken014

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


  30 in total

1.  Changes in apoptotic gene expression in lymphocytes from rheumatoid arthritis and systemic lupus erythematosus patients compared with healthy lymphocytes.

Authors:  Paul Eggleton; Lorna W Harries; Giada Alberigo; Paul Wordsworth; Nick Viner; Richard Haigh; Suzanne Donnelly; Hugh W Jones; Ian C Chikanza; Thomas W E O'Conner; Alasdair E R Thomson; Paul G Winyard
Journal:  J Clin Immunol       Date:  2010-06-09       Impact factor: 8.317

Review 2.  Recent advances in the molecular design of synthetic vaccines.

Authors:  Lyn H Jones
Journal:  Nat Chem       Date:  2015-12       Impact factor: 24.427

3.  Characterization of recombinant human IL-15 deamidation and its practical elimination through substitution of asparagine 77.

Authors:  David F Nellis; Dennis F Michiel; Man-Shiow Jiang; Dominic Esposito; Richard Davis; Hengguang Jiang; Angela Korrell; George C Knapp; Lauren E Lucernoni; Roy E Nelson; Emily M Pritt; Lauren V Procter; Mark Rogers; Terry L Sumpter; Vinay V Vyas; Timothy J Waybright; Xiaoyi Yang; Amy M Zheng; Jason L Yovandich; John A Gilly; George Mitra; Jianwei Zhu
Journal:  Pharm Res       Date:  2011-10-19       Impact factor: 4.200

4.  DEK in the synovium of patients with juvenile idiopathic arthritis: characterization of DEK antibodies and posttranslational modification of the DEK autoantigen.

Authors:  Nirit Mor-Vaknin; Ferdinand Kappes; Amalie E Dick; Maureen Legendre; Catalina Damoc; Seagal Teitz-Tennenbaum; Roland Kwok; Elisa Ferrando-May; Barbara S Adams; David M Markovitz
Journal:  Arthritis Rheum       Date:  2011-02

Review 5.  Autoantibodies in primary sclerosing cholangitis.

Authors:  Johannes-Roksund Hov; Kirsten-Muri Boberg; Tom-H Karlsen
Journal:  World J Gastroenterol       Date:  2008-06-28       Impact factor: 5.742

6.  4-Hydroxynonenal-modified Ro 60 autoantigen accelerates autoimmunity in experimental animals.

Authors:  B T Kurien; R H Scofield
Journal:  Rheumatology (Oxford)       Date:  2008-08-02       Impact factor: 7.580

7.  Immunogenicity of autoantigens.

Authors:  Christina Backes; Nicole Ludwig; Petra Leidinger; Christian Harz; Jana Hoffmann; Andreas Keller; Eckart Meese; Hans-Peter Lenhof
Journal:  BMC Genomics       Date:  2011-07-04       Impact factor: 3.969

Review 8.  Mass spectrometric analysis of asparagine deamidation and aspartate isomerization in polypeptides.

Authors:  Hongqian Yang; Roman A Zubarev
Journal:  Electrophoresis       Date:  2010-06       Impact factor: 3.535

9.  Identification of novel autoantigens by a triangulation approach.

Authors:  Tricia R Cottrell; John C Hall; Antony Rosen; Livia Casciola-Rosen
Journal:  J Immunol Methods       Date:  2012-08-11       Impact factor: 2.303

10.  Increased concentration of two different advanced glycation end-products detected by enzyme immunoassays with new monoclonal antibodies in sera of patients with rheumatoid arthritis.

Authors:  Richard Vytásek; Liliana Sedová; Vladimír Vilím
Journal:  BMC Musculoskelet Disord       Date:  2010-05-03       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.